# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA302007 | 8f | IC50 | 0 | ALA4362815 | Not Determined | Leishmania donovani | |||||
2. | ALA302007 | 8f | EC50 | = | 11.8 | uM | ALA4362809 | 4.93 | nM | Leishmania donovani | ||
3. | ALA302007 | 8f | Ratio CC50/EC50 | = | 69.1 | ALA4362808 | ||||||
4. | ALA302007 | 8f | CC50 | = | 79.97 | uM | ALA4362807 | nM | Homo sapiens | |||
5. | ALA302007 | 8f | CC50 | = | 145.09 | uM | ALA4362806 | nM | Homo sapiens | |||
6. | ALA302007 | 8f | EC50 | = | 2.1 | uM | ALA4362804 | 5.68 | nM | Leishmania donovani | ||
7. | ALA302007 | 8f | PPB | = | 90 | % | ALA1840106 | % | ||||
8. | ALA302007 | 8f | HIA | > | 95 | % | ALA1840105 | % | Homo sapiens | |||
9. | ALA302007 | 8f | INH | 0 | ALA1840110 | Not Determined | % | Plasmodium berghei | ||||
10. | ALA302007 | 8f | INH | = | 7 | % | ALA1840108 | % | Plasmodium berghei | |||
11. | ALA302007 | 8f | IC50 | = | 0.12 | uM | ALA1840103 | 6.92 | nM | Plasmodium falciparum | ||
12. | ALA302007 | 8f | Ratio IC50 | = | 8.3 | ALA1840104 | Plasmodium falciparum | |||||
13. | ALA302007 | 8f | CC50 | > | 16 | uM | ALA1840107 | nM | Chlorocebus aethiops | |||
14. | ALA302007 | 8f | Activity | = | 41.9 | % | ALA888102 | % | Mus musculus | |||
15. | ALA302007 | 8f | Activity | = | 62.6 | % | ALA888099 | % | Mus musculus | |||
16. | ALA302007 | 8f | Inhibition | < | 0 | % | ALA854584 | % | Homo sapiens | |||
17. | ALA302007 | 8f | Inhibition | = | 38.4 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
18. | ALA302007 | 8f | IC50 | = | 71 | uM | ALA854587 | 4.15 | nM | Human immunodeficiency virus | ||
19. | ALA302007 | 8f | CC50 | > | 168 | uM | ALA863595 | nM | ||||
20. | ALA302007 | 8f | Ratio CC50/IC50 | = | 2.4 | ALA863596 | Human immunodeficiency virus |